SCHEMBL14905995

SCHEMBL14905995

C=C/C(=C\C=N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18536299 0.78
SCHEMBL5383072 0.78
SCHEMBL329436 0.78
SCHEMBL23222761 0.74 ALDH1A1 (0.36)
SCHEMBL21926752 0.74
SCHEMBL23609757 0.73 TSHR (0.30)
SCHEMBL24031204 0.72 ALDH1A1 (0.35)
SCHEMBL15121166 0.72
SCHEMBL14543055 0.72
SCHEMBL16938589 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725775-A1 PYRIDINE- AND PYRIMIDINECARBOXAMIDES AS CXCR2 MODULATORS Syntrix Biosystems, Inc. (US) 2020-10-21 EP disclosed
US-10392381-B2 Prevention and treatment of non-alcoholic fatty liver disease OHIO UNIVERSITY (US) 2019-08-27 US disclosed
US-20130109684-A1 GRP94 INHIBITORS UNIVERSITY OF KANSAS (US) 2013-05-02 US disclosed